Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease

被引:7
|
作者
Rivero, Jesus [1 ]
Rodriguez, Francisco [2 ]
Soto, Virgilia [2 ]
Macedo, Etienne [3 ]
Chawla, Lakhmir S. [3 ]
Mehta, Ravindra L. [3 ]
Vaingankar, Sucheta [2 ]
Garimella, Pranav S. [3 ]
Garza, Carlos [2 ]
Madero, Magdalena [2 ]
机构
[1] Natl Inst Lung Dis Ismael Cosio Villegas, Nephrol Dept, Mexico City, DF, Mexico
[2] Natl Inst Cardiol Ignacio Chavez, Nephrol Dept, Juan Badiano 1, Mexico City 14080, DF, Mexico
[3] Univ Calif San Diego, Div Nephrol, San Diego, CA 92103 USA
关键词
Interstitial fibrosis; Uresis; Kidney biopsy; Furosemide stress test; SERUM CREATININE; DIFFERENTIAL-DIAGNOSIS; COCKCROFT-GAULT; TUBULAR ATROPHY; RENAL-FUNCTION; MARKERS; CLEARANCE; MECHANISMS; PREDICTION; EQUATIONS;
D O I
10.1186/s12882-020-01721-z
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Interstitial fibrosis (IF) on kidney biopsy is one of the most potent risk factors for kidney disease progression. The furosemide stress test (FST) is a validated tool that predicts the severity of acute kidney injury (especially at 2 h) in critically ill patients. Since furosemide is secreted through the kidney tubules, the response to FST represents the tubular secretory capacity. To our knowledge there is no data on the correlation between functional tubular capacity assessed by the FST with IF on kidney biopsies from patients with chronic kidney disease (CKD). The aim of this study was to determine the association between urine output (UO), Furosemide Excreted Mass (FEM) and IF on kidney biopsies after a FST. Methods This study included 84 patients who underwent kidney biopsy for clinical indications and a FST. The percentage of fibrosis was determined by morphometry technique and reviewed by a nephropathologist. All patients underwent a FST prior to the biopsy. Urine volume and urinary sodium were measured in addition to urine concentrations of furosemide at different times (2, 4 and 6 h). We used an established equation to determine the FEM. Values were expressed as mean, standard deviation or percentage and Pearson Correlation. Results The mean age of the participants was 38 years and 44% were male. The prevalence of diabetes mellitus, hypertension and diuretic use was significantly higher with more advanced degree of fibrosis. Nephrotic syndrome and acute kidney graft dysfunction were the most frequent indications for biopsy. eGFR was inversely related to the degree of fibrosis. Subjects with the highest degree of fibrosis (grade 3) showed a significant lower UO at first hour of the FST when compared to lower degrees of fibrosis (p = 0.015). Likewise, the total UO and the FEM was progressively lower with higher degrees of fibrosis. An inversely linear correlation between FEM and the degree of fibrosis (r = - 0.245, p = 0.02) was observed. Conclusions Our findings indicate that interstitial fibrosis correlates with total urine output and FEM. Further studies are needed to determine if UO and FST could be a non-invasive tool to evaluate interstitial fibrosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Evaluation of interstitial fibrosis in chronic kidney disease by multiparametric functional MRI and histopathologic analysis
    Mao, Wei
    Ding, Xiaoqiang
    Ding, Yuqin
    Cao, Bohong
    Fu, Caixia
    Kuehn, Bernd
    Benkert, Thomas
    Grimm, Robert
    Nickel, Dominik
    Zhou, Jianjun
    Zeng, Mengsu
    EUROPEAN RADIOLOGY, 2023, 33 (06) : 4138 - 4147
  • [22] Evaluation of interstitial fibrosis in chronic kidney disease by multiparametric functional MRI and histopathologic analysis
    Wei Mao
    Xiaoqiang Ding
    Yuqin Ding
    Bohong Cao
    Caixia Fu
    Bernd Kuehn
    Thomas Benkert
    Robert Grimm
    Dominik Nickel
    Jianjun Zhou
    Mengsu Zeng
    European Radiology, 2023, 33 : 4138 - 4147
  • [23] Banff Fibrosis Study: Multicenter Visual Assessment and Computerized Analysis of Interstitial Fibrosis in Kidney Biopsies
    Farris, A. B.
    Chan, S.
    Climenhaga, J.
    Adam, B.
    Bellamy, C. O. C.
    Seron, D.
    Colvin, R. B.
    Reeve, J.
    Mengel, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (04) : 897 - 907
  • [24] The Banff Fibrosis Trial for Reproducibility and Clinical Significance of Visual Assessment of Interstitial Fibrosis in Kidney Biopsies
    Farris, A. B.
    Chan, S.
    Climenhaga, J.
    Bellamy, C.
    Seron, D.
    Colvin, R.
    Mengel, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 81 - 82
  • [25] CHRONIC KIDNEY DISEASE PLD4 regulates kidney fibrosis
    Carney, Ellen F.
    NATURE REVIEWS NEPHROLOGY, 2017, 13 (10) : 597 - 597
  • [26] INDICATORS OF FIBROSIS IN CHILDREN WITH CHRONIC KIDNEY DISEASE
    Musial, Kinga
    Zwolinska, Danuta
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 37 - 37
  • [27] Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences
    Panizo, Sara
    Martinez-Arias, Laura
    Alonso-Montes, Cristina
    Cannata, Pablo
    Martin-Carro, Beatriz
    Fernandez-Martin, Jose L.
    Naves-Diaz, Manuel
    Carrillo-Lopez, Natalia
    Cannata-Andia, Jorge B.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (01) : 1 - 19
  • [28] Role of Uremic Toxins, Oxidative Stress, and Renal Fibrosis in Chronic Kidney Disease
    Frak, Weronika
    Dabek, Bartlomiej
    Balcerczyk-Lis, Marta
    Motor, Jakub
    Radzioch, Ewa
    Mlynarska, Ewelina
    Rysz, Jacek
    Franczyk, Beata
    ANTIOXIDANTS, 2024, 13 (06)
  • [29] The role of macrophages in fibrosis of chronic kidney disease
    Li, Guangtao
    Yang, Hongxia
    Zhang, Dan
    Zhang, Yanghe
    Liu, Bin
    Wang, Yuxiong
    Zhou, Honglan
    Xu, Zhi-Xiang
    Wang, Yishu
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 177
  • [30] PROGRESSION OF MYOCARADIAL FIBROSIS IN CHRONIC KIDNEY DISEASE
    Hayer, Manvir
    Price, Anna
    Liu, Boyang
    Baig, Shanat
    Ferro, Charles J.
    Townend, John
    Steeds, Rick
    Edwards, Nicky
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34